Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb501b17465442e38d579903e5873ff1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:eb501b17465442e38d579903e5873ff1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:eb501b17465442e38d579903e5873ff12021-11-18T08:46:57ZActivation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?1932-620310.1371/journal.pone.0078474https://doaj.org/article/eb501b17465442e38d579903e5873ff12013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24236019/?tool=EBIhttps://doaj.org/toc/1932-6203The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the potentially neuropathogenic HERV-W/MSRV/Syncytin-1 endogenous retroviruses. The ascertained links between EBV and MS are history of late primary infection, possibly leading to infectious mononucleosis (IM), and high titers of pre-onset IgG against EBV nuclear antigens (anti-EBNA IgG). During MS, there is no evidence of MS-specific EBV expression, while a continuous expression of HERV-Ws occurs, paralleling disease behaviour. We found repeatedly extracellular HERV-W/MSRV and MSRV-specific mRNA sequences in MS patients (in blood, spinal fluid, and brain samples), and MRSV presence/load strikingly paralleled MS stages and active/remission phases. Aim of the study was to verify whether HERV-W might be activated in vivo, in hospitalized young adults with IM symptoms, that were analyzed with respect to expression of HERV-W/MSRV transcripts and proteins. Healthy controls were either EBV-negative or latently EBV-infected with/without high titers of anti-EBNA-1 IgG. The results show that activation of HERV-W/MSRV occurs in blood mononuclear cells of IM patients (2Log10 increase of MSRV-type env mRNA accumulation with respect to EBV-negative controls). When healthy controls are stratified for previous EBV infection (high and low, or no anti-EBNA-1 IgG titers), a direct correlation occurs with MSRV mRNA accumulation. Flow cytometry data show increased percentages of cells exposing surface HERV-Wenv protein, that occur differently in specific cell subsets, and in acute disease and past infection. Thus, the data indicate that the two main links between EBV and MS (IM and high anti-EBNA-1-IgG titers) are paralleled by activation of the potentially neuropathogenic HERV-W/MSRV. These novel findings suggest HERV-W/MSRV activation as the missing link between EBV and MS, and may open new avenues of intervention.Giuseppe MameliGiordano MadedduAlessandra MeiElena UleriLuciana PoddigheLucia G DeloguIvana MaidaSergio BabudieriCaterina SerraRoberto ManettiMaria S MuraAntonina DoleiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e78474 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Giuseppe Mameli Giordano Madeddu Alessandra Mei Elena Uleri Luciana Poddighe Lucia G Delogu Ivana Maida Sergio Babudieri Caterina Serra Roberto Manetti Maria S Mura Antonina Dolei Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? |
description |
The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the potentially neuropathogenic HERV-W/MSRV/Syncytin-1 endogenous retroviruses. The ascertained links between EBV and MS are history of late primary infection, possibly leading to infectious mononucleosis (IM), and high titers of pre-onset IgG against EBV nuclear antigens (anti-EBNA IgG). During MS, there is no evidence of MS-specific EBV expression, while a continuous expression of HERV-Ws occurs, paralleling disease behaviour. We found repeatedly extracellular HERV-W/MSRV and MSRV-specific mRNA sequences in MS patients (in blood, spinal fluid, and brain samples), and MRSV presence/load strikingly paralleled MS stages and active/remission phases. Aim of the study was to verify whether HERV-W might be activated in vivo, in hospitalized young adults with IM symptoms, that were analyzed with respect to expression of HERV-W/MSRV transcripts and proteins. Healthy controls were either EBV-negative or latently EBV-infected with/without high titers of anti-EBNA-1 IgG. The results show that activation of HERV-W/MSRV occurs in blood mononuclear cells of IM patients (2Log10 increase of MSRV-type env mRNA accumulation with respect to EBV-negative controls). When healthy controls are stratified for previous EBV infection (high and low, or no anti-EBNA-1 IgG titers), a direct correlation occurs with MSRV mRNA accumulation. Flow cytometry data show increased percentages of cells exposing surface HERV-Wenv protein, that occur differently in specific cell subsets, and in acute disease and past infection. Thus, the data indicate that the two main links between EBV and MS (IM and high anti-EBNA-1-IgG titers) are paralleled by activation of the potentially neuropathogenic HERV-W/MSRV. These novel findings suggest HERV-W/MSRV activation as the missing link between EBV and MS, and may open new avenues of intervention. |
format |
article |
author |
Giuseppe Mameli Giordano Madeddu Alessandra Mei Elena Uleri Luciana Poddighe Lucia G Delogu Ivana Maida Sergio Babudieri Caterina Serra Roberto Manetti Maria S Mura Antonina Dolei |
author_facet |
Giuseppe Mameli Giordano Madeddu Alessandra Mei Elena Uleri Luciana Poddighe Lucia G Delogu Ivana Maida Sergio Babudieri Caterina Serra Roberto Manetti Maria S Mura Antonina Dolei |
author_sort |
Giuseppe Mameli |
title |
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? |
title_short |
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? |
title_full |
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? |
title_fullStr |
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? |
title_full_unstemmed |
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? |
title_sort |
activation of msrv-type endogenous retroviruses during infectious mononucleosis and epstein-barr virus latency: the missing link with multiple sclerosis? |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/eb501b17465442e38d579903e5873ff1 |
work_keys_str_mv |
AT giuseppemameli activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT giordanomadeddu activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT alessandramei activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT elenauleri activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT lucianapoddighe activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT luciagdelogu activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT ivanamaida activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT sergiobabudieri activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT caterinaserra activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT robertomanetti activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT mariasmura activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis AT antoninadolei activationofmsrvtypeendogenousretrovirusesduringinfectiousmononucleosisandepsteinbarrviruslatencythemissinglinkwithmultiplesclerosis |
_version_ |
1718421357930217472 |